These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36015100)

  • 1. Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials.
    Li H; Yang A; Zhao S; Chow EY; Javanbakht M; Li Y; Lin D; Xu L; Zang D; Wang K; Ma L
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four kinds of traditional Chinese exercise therapy in the treatment of type 2 diabetes: a systematic review and network meta-analysis.
    Jia Y; Huang H; Yu Y; Jia H; Zhang Y
    Syst Rev; 2023 Dec; 12(1):231. PubMed ID: 38093392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.
    Zaccardi F; Dhalwani NN; Dales J; Mani H; Khunti K; Davies MJ; Webb DR
    Diabetes Obes Metab; 2018 Apr; 20(4):985-997. PubMed ID: 29205774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis of
    Pan L; Zhai X; Duan Z; Xu K; Liu G
    Front Pharmacol; 2022; 13():956313. PubMed ID: 36160405
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of traditional Chinese medicines combined with conventional Western medicines in the treatment of type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials.
    Ma K; Zhou L; Zhang Y; Zhao J; Yao C; Tian C; Li M
    Front Endocrinol (Lausanne); 2023; 14():1134297. PubMed ID: 37223050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
    Lan J; Zhao Y; Dong F; Yan Z; Zheng W; Fan J; Sun G
    J Ethnopharmacol; 2015 Feb; 161():69-81. PubMed ID: 25498346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Meta-analysis of the Therapeutic Effects of Hypoglycemic Drugs and Intensive Lifestyle Modification on Impaired Glucose Tolerance.
    Zhang Y; Fu Y; Mu YM; Huang Y; Xuan J
    Clin Ther; 2021 Sep; 43(9):1524-1556. PubMed ID: 34452739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of different insulin infusion methods in the treatment of total parenteral nutrition-associated hyperglycemia: a systematic review and network meta-analysis.
    Cao L; Zhang D; Zhao Y; Zhou N; Zhang P
    Front Nutr; 2023; 10():1181359. PubMed ID: 37674887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J; West HM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.
    Avgerinos I; Manolopoulos A; Michailidis T; Kitsios K; Liakos A; Karagiannis T; Dimitrakopoulos K; Matthews DR; Tsapas A; Bekiari E
    Diabetes Obes Metab; 2021 Mar; 23(3):822-831. PubMed ID: 33300282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin combined with acarbose vs. single medicine in the treatment of type 2 diabetes: A meta-analysis.
    Liu Z; Zhao X; Sun W; Wang Y; Liu S; Kang L
    Exp Ther Med; 2017 Jun; 13(6):3137-3145. PubMed ID: 28588669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus.
    Wang RR; Lv ZM; Dan YP; Chen KY; Zhang C
    J Biol Regul Homeost Agents; 2019; 33(2):365-374. PubMed ID: 30972995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Zhang F; Xu S; Tang L; Pan X; Tong N
    Front Endocrinol (Lausanne); 2020; 11():288. PubMed ID: 32582019
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials.
    Wu S; Gao L; Cipriani A; Huang Y; Yang Z; Yang J; Yu S; Zhang Y; Chai S; Zhang Z; Sun F; Zhan S
    Diabetes Obes Metab; 2019 Apr; 21(4):975-983. PubMed ID: 30536884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.
    Kramer CK; Ye C; Campbell S; Retnakaran R
    JACC Heart Fail; 2018 Oct; 6(10):823-830. PubMed ID: 30196071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Li WX; Gou JF; Tian JH; Yan X; Yang L
    Curr Ther Res Clin Exp; 2010 Aug; 71(4):211-38. PubMed ID: 24688145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.